SCOPUS 정보 검색 플랫폼

Volumn 62, Issue 8, 2002, Pages 2300-2305

S-3-amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice

(8) Lentzsch, Suzanne a Rogers, Michael S b LeBlanc, Richard a Birsner, Amy E b Shah, Jamshed H c Treston, Anthony M c Anderson, Kenneth C a D’Amato, Robert J b

a HARVARD MEDICAL SCHOOL (United States)

b BOSTON CHILDREN S HOSPITAL (United States)

c ENTREMED INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

S 3 (3 AMINOPHTHALIMIDO)GLUTARIMIDE; THALIDOMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD DISEASE; BONE MARROW TOXICITY; BURKITT LYMPHOMA; CANCER GROWTH; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BURKITT LYMPHOMA; CARCINOMA, LEWIS LUNG; CELL DIVISION; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, SCID; MULTIPLE MYELOMA; NEOVASCULARIZATION, PHYSIOLOGIC; THALIDOMIDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037089554 PISSN: 00085472 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (91)

References (31)

1
- 0032726481
- Immunmodulation by thalidomide and thalidomide analogues
- (1999) Ann. Rheum. Dis. , vol.58 , pp. 1107-1113
- Corral, L.¹ Kaplan, G.²

2
- 0028216334
- Thalidomide is an inhibitor of angiogenesis
- (1994) Proc. Natl. Acad. Sci. USA , vol.91 , pp. 4082-4085
- D'Amato, R.J.¹ Loughman, M.S.² Flynn, E.³ Folkman, J.⁴

3
- 0027304271
- The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum
- (1993) J. Infect. Dis. , vol.168 , pp. 408-414
- Sampaio, E.P.¹ Kaplan, G.² Miranda, A.³ Nery, J.A.⁴ Miguel, C.P.⁵ Viana, S.M.⁶ Sarno, E.N.⁷

4
- 0033980850
- Continuous low dose thalidomide: A Phase II study in advanced melanoma, renal cell, ovarian and breast cancer
- (2000) Br. J. Cancer , vol.82 , pp. 812-817
- Eisen, T.¹ Boshoff, C.² Mak, I.³ Sapunar, F.⁴ Vaughan, M.M.⁵ Pyle, L.⁶ Johnston, S.R.⁷ Ahem, R.⁸ Smith, I.E.⁹ Gore, M.E.¹⁰

5
- 0033902037
- Prognostic value of bone marrow angiogenesis in multiple myeloma
- (2000) Clin. Cancer Res. , vol.6 , pp. 3111-3116
- Rajkumar, S.V.¹ Leong, T.² Roche, P.C.³ Fonseca, R.⁴ Dispenzieri, A.⁵ Lacy, M.Q.⁶ Lust, J.A.⁷ Witzig, T.E.⁸ Kyle, R.A.⁹ Gertz, M.A.¹⁰ Greipp, P.R.¹¹

6
- 0032903871
- Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
- (1999) Br. J. Cancer , vol.79 , pp. 451-455
- Ribatti, D.¹ Vacca, A.² Nico, B.³ Quondamatteo, F.⁴ Ria, R.⁵ Minischetti, M.⁶ Marzullo, A.⁷ Herken, R.⁸ Roncali, L.⁹ Dammacco, F.¹⁰

7
- 0033134764
- Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
- (1999) Blood , vol.93 , pp. 3064-3073
- Vacca, A.¹ Ribatti, D.² Presta, M.³ Minischetti, M.⁴ Iurlaro, M.⁵ Ria, R.⁶ Albini, A.⁷ Bussolino, F.⁸ Dammacco, F.⁹

8
- 0032748385
- Antitumor activity of thalidomide in refractory multiple myeloma
- (1999) N. Engl. J. Med. , vol.341 , pp. 1565-1571
- Singhal, S.¹ Mehia, J.² Desikan, R.³ Ayers, D.⁴ Robergon, P.⁵ Eddlemon, P.⁶ Munshi, N.⁷ Anaissie, E.⁸ Wilson, C.⁹ Dhodapkar, M.¹⁰ Zeddis, J.¹¹ Barlogie, B.¹²

9
- 0036464605
- Efficacy and safety of thalidomide in patients with acute myeloid leukemia
- (2002) Blood , vol.99 , pp. 834-839
- Steins, M.B.¹ Padro, T.² Bieker, R.³ Ruiz, S.⁴ Kropff, M.⁵ Kienast, J.⁶ Kessler, T.⁷ Buechner, T.⁸ Berdel, W.E.⁹ Mesters, R.M.¹⁰

10
- 0034331194
- Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
- (2000) Blood , vol.96 , pp. 2943-2950
- Hideshima, T.¹ Chauhan, D.² Shima, Y.³ Raje, N.⁴ Davies, F.E.⁵ Tai, Y.T.⁶ Treon, S.P.⁷ Lin, B.⁸ Schlossman, R.L.⁹ Richardson, P.¹⁰ Muller, G.¹¹ Stirling, D.I.¹² Anderson, K.C.¹³

11
- 0033532557
- Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production
- (1999) Bioorg. Med. Chem. Lett. , vol.9 , pp. 1625-1630
- Muller, G.¹ Chen, R.² Huang, S.Y.³ Corral, L.G.⁴ Wong, L.M.⁵ Patterson, R.T.⁶ Chen, Y.⁷ Kaplan, G.⁸ Stirling, D.I.⁹

12
- 0033083962
- Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
- (1999) Cancer Res. , vol.59 , pp. 728-733
- Bellamy, W.T.¹ Richter, L.² Frutiger, Y.³ Grogan, T.M.⁴

13
- 0034655957
- Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma
- (2000) Blood , vol.95 , pp. 2630-2336
- Dankbar, B.¹ Padro, T.² Leo, R.³ Feldmann, B.⁴ Kropff, M.⁵ Mesters, R.M.⁶ Serve, H.⁷ Berdel, W.E.⁸ Kienast, J.⁹

14
- 0035880256
- Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
- (2001) Blood , vol.98 , pp. 428-435
- Podar, K.¹ Tai, Y.T.² Davies, F.E.³ Lentzsch, S.⁴ Sattler, M.⁵ Hideshima, T.⁶ Lin, B.K.⁷ Gupta, D.⁸ Shima, Y.⁹ Chauhan, D.¹⁰ Mitsiades, C.¹¹ Raje, N.¹² Richardson, P.¹³ Anderson, K.C.¹⁴

15
- 0031711326
- Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia
- (1998) Leuk. Lymphoma , vol.31 , pp. 167-175
- Witzig, T.E.¹ Kimlinger, T.² Stenson, M.³ Therneau, T.⁴

16
- 0035121440
- Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF) vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
- (2001) Eur. J. Haematol. , vol.66 , pp. 83-88
- Sezer, O.¹ Jakob, C.² Eucker, J.³ Niemoller, K.⁴ Gatz, F.⁵ Wernecke, K.⁶ Possinger, K.⁷

17
- 0033835945
- Angiogenic factors in multiple myeloma: Higher levels in bone marrow than in peripheral blood
- (2000) Haematologica , vol.85 , pp. 800-805
- Di Raimondo, F.¹ Azzaro, M.P.² Palumbo, G.³ Bagnato, S.⁴ Giustoliusi, G.⁵ Floridia, P.⁶ Sortino, G.⁷ Goustolisi, R.⁸

18
- 0034903286
- Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers
- (2001) Ann. Oncol. , vol.12 , pp. 987-990
- Bertolini, F.¹

19
- 0035211504
- Angiogenesis-dependent diseases
- (2001) Semin. Oncol. , vol.28 , pp. 536-542
- Folkman, J.F.¹

20
- 0034116011
- Thalidomide: Therapeutic potential in hematologic malignancies
- (2000) Semin. Hematol. , vol.37 , pp. 1-4
- Anderson, K.C.¹

21
- 0035412366
- Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
- (2001) Blood , vol.98 , pp. 210-216
- Davies, F.E.¹ Raje, N.² Hideshima, T.³ Lentzsch, S.⁴ Young, G.⁵ Tai, Y.T.⁶ Lin, B.⁷ Podar, K.⁸ Gupta, D.⁹ Chauhan, D.¹⁰ Treon, S.P.¹¹ Richardson, P.G.¹² Schlossman, R.L.¹³ Morgan, G.J.¹⁴ Muller, G.W.¹⁵ Stirling, D.I.¹⁶ Anderson, K.C.¹⁷

22
- 0032100604
- Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent
- (1998) Biochem. Pharmacol. , vol.55 , pp. 1827-1834
- Bauer, K.S.¹ Dixon, S.C.² Figg, W.D.³

23
- 0015463570
- Chemical structure and teratogenic properties. III. A review of available data on structure-activity relationships and mechanism of action of thalidomide analogues
- (1972) Acta Pharm. Suec. , vol.9 , pp. 521-542
- Jonsson, N.A.¹

24
- 0035761419
- Cross-contamination: HS-Sultan is not a myeloma but a Burkitt lymphoma cell line
- (2001) Blood , vol.98 , pp. 3495-3496
- Drexler, H.G.¹ MacLeod, R.A.F.² Dirks, W.G.³

25
- 0033974904
- Isolation and characterization of human multiple myeloma cell enriched populations
- (2000) J. Immunol. Methods , vol.235 , pp. 11-19
- Tai, Y.T.¹ Teoh, G.² Shima, Y.³ Chauhan, D.⁴ Treon, S.P.⁵ Raje, N.⁶ Hideshima, T.⁷ Davies, F.E.⁸ Anderson, K.C.⁹

26
- 0035452345
- The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells
- (2001) Int. J. Cancer , vol.93 , pp. 674-680
- Hönemann, D.¹ Chatterjee, M.² Savino, R.³ Bommert, K.⁴ Burger, R.⁵ Gramatzki, M.⁶ Dorken, B.⁷ Bargou, R.C.⁸

27
- 0344791636
- Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: A pilot study
- (1999) Exp. Hematol. , vol.27 , pp. 169-175
- Mapara, M.Y.¹ Korner, I.J.² Lentzsch, S.³ Krahl, D.⁴ Reichardt, P.⁵ Dorken, B.⁶

28
- 0027970092
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
- (1994) Cell , vol.79 , pp. 315-328
- O'Reilly, M.S.¹ Holmgren, L.² Shing, Y.³ Chen, C.⁴ Rosenthal, R.A.⁵ Moses, M.⁶ Lane, W.S.⁷ Cao, Y.⁸ Sage, E.H.⁹ Folkman, J.¹⁰

29
- 0029739615
- A model of angiogenesis in the mouse cornea
- (1996) Investig. Ophtalmol. Vis. Sci. , vol.37 , pp. 1625-1632
- Kenyon, B.M.¹ Voest, E.E.² Chen, C.C.³ Folkman, J.⁴ D'Amato, R.J.⁵

30
- 0031015504
- Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and Taxol
- (1997) Cancer Res. , vol.57 , pp. 81-86
- Klauber, N.¹ Parangi, S.² Flynn, E.³ Hamel, E.⁴ D'Amato, R.J.⁵

31
- 0026083903
- Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
- (1991) N. Engl. J. Med. , vol.324 , pp. 1-8
- Weidner, N.¹ Semple, J.P.² Welch, W.R.³ Folkman, J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.